| abstract |
The present disclosure relates to a compositoin comprising a Salvia miltiorrhiza Bunge extract as an active ingredient for treatment or prevention of benign prostatic hyperplasia or alopecia, the Salvia miltiorrhiza Bunge extract being characteized by containing tanshinones in 2-70%, including tanshinone1, tanshinone2a, cryptotanshinone, and dihydrotanshinone, and can provide a pharmaceutical compositoin and a helath fucntional food for treatment or prevention of alopecia and benign prostatic hyperplasia. |